Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Sam Altman Says He's Changed His Mind on Donald Trump
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman Doesn’t Actually Need Trump
Donald Trump says his big new AI initiative is a victory for America. Guess who the real winner is.
Cathie Wood Dumped Sam Altman's Surging Nuclear Startup. The Stock Just Received A 70% Price Target Hike.
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...
Altman-backed biotech firm eyes $1B
Retro Biosciences is raising $1 billion, with the ultimate goal of using its customized AI to extend human lifespan by 10 ...
Super Micro Computer, Inc. (SMCI): Powering AI and Cloud Growth with High-Performance Solutions
We recently published a list of 10 AI News You Should Definitely Take a Look At. In this article, we are going to take a look ...